Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipient - PubMed (original) (raw)
Editorial
. 2017 Dec;17(12):3001-3002.
doi: 10.1111/ajt.14479. Epub 2017 Sep 23.
Affiliations
- PMID: 28858427
- DOI: 10.1111/ajt.14479
Free article
Editorial
Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipient
Peter G Stock. Am J Transplant. 2017 Dec.
Free article
No abstract available
Keywords: clinical research/practice; immunosuppressive regimens; infection and infectious agents - viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS); kidney (allograft) function/dysfunction; kidney transplantation/nephrology.
Comment on
- Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
Sawinski D, Shelton BA, Mehta S, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE. Sawinski D, et al. Am J Transplant. 2017 Dec;17(12):3114-3122. doi: 10.1111/ajt.14419. Epub 2017 Aug 24. Am J Transplant. 2017. PMID: 28696079
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical